首页> 外国专利> Tumor stem cell line isolated from a recurrent pineoblastoma patient and patient specific xenograft animal model for recurrent pineoblastoma

Tumor stem cell line isolated from a recurrent pineoblastoma patient and patient specific xenograft animal model for recurrent pineoblastoma

机译:从复发性成皮细胞瘤患者中分离的肿瘤干细胞系和复发性成皮细胞瘤患者特异性异种移植动物模型

摘要

The present invention relates to a novel stem cell line isolated from a recurrent pineoblastoma patient, a method for separating and culturing the same, a patient-customized xenograft animal model using the stem cell line, and a use of the same. A recurrent pineoblastoma stem cell line (donation number: KCLRF-BP-00358) provided according to the present invention is a malignant tumoric stem cell line having a very short survival period, and can be very useful in performing a diagnosis and developing a treating agent with respect to the cause of occurrence, the metastasis, the invasion, and the reoccurrence of pineoblastoma. Moreover, a recurrent pineoblastoma animal model provided according to the present invention has pineoblastoma showing morphological and genetic properties which are identical to a recurrent pineoblastoma patient, thereby being able to be utilized in more safely and effectively developing a patient-customized recurrent pineoblastoma treating agent.
机译:本发明涉及从复发的成血管母细胞瘤患者中分离的新型干细胞系,分离和培养该干细胞系的方法,使用该干细胞系的患者定制的异种移植动物模型及其用途。根据本发明提供的复发性成胚细胞瘤干细胞系(捐赠编号:KCLRF-BP-00358)是具有非常短的存活期的恶性肿瘤干细胞系,并且在进行诊断和开发治疗剂中可以非常有用。关于成瘤细胞的发生原因,转移,侵袭和复发。此外,根据本发明提供的复发性成纤维细胞瘤动物模型具有表现出与复发性成纤维细胞瘤患者相同的形态和遗传特性的成纤维细胞瘤,从而能够更安全有效地用于开发患者定制的复发性成纤维细胞瘤治疗剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号